← Every lobbying firm
Avenue Solutions
A registered lobbying firm, and the clients it files for. Everything here comes from the quarterly disclosures it is required to make under the Lobbying Disclosure Act. Filed as AVENUE SOLUTIONS.
Clients
17
named in its filings
Filings
31
2026
Fees reported
$1.5M
across every filing
Who it represents
Largest first, by what the filings report being paid.
| Client | Fees |
|---|---|
| Unitedhealth Group IncUnitedHealth Group Inc | $220K |
| Bristol-Myers Squibb CompanyBristol-Myers Squibb Co | $120K |
| Illumina, Inc.Illumina Inc | $120K |
| Incyte CorporationIncyte Corp | $120K |
| Apollo Global Management, Inc.Apollo Global Management Inc | $120K |
| Fresenius Medical Care North AmericaFresenius Medical Care AG | $120K |
| Moderna, Inc.Moderna Inc | $100K |
| Edwards Lifesciences LLCEdwards Lifesciences Corp | $100K |
| Merck & Co. Inc.Merck & Co Inc | $100K |
| Jazz Pharmaceuticals, Inc.Jazz Pharmaceuticals PLC | $100K |
| Jpmorgan Chase Holdings LLCJPMorgan Chase & Co | $60K |
| Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals Inc | $60K |
| Large Urology Group Practice AssociationPRA Group Inc | $60K |
| Oracle CorporationOracle Corp | $60K |
| Compass Pathways, Inc.Compass Inc | $30K |
| Takeda Pharmaceuticals America, Inc.Takeda Pharmaceutical Co Ltd | $20K |
| Medical Information Technology, Inc.Informa PLC | — |
Every filing
Newest first, and within a year the largest.
| Client | Fee |
|---|---|
| Unitedhealth Group Inc | $120K |
| Unitedhealth Group Inc | $100K |
| Vertex Pharmaceuticals Incorporated | $60K |
| Large Urology Group Practice Association | $60K |
| Illumina, Inc. | $60K |
| Incyte Corporation | $60K |
| Apollo Global Management, Inc. | $60K |
| Oracle Corporation | $60K |
| Fresenius Medical Care North America | $60K |
| Fresenius Medical Care North America | $60K |
| Illumina, Inc. | $60K |
| Incyte Corporation | $60K |
| Apollo Global Management, Inc. | $60K |
| Bristol-Myers Squibb Company | $60K |
| Bristol-Myers Squibb Company | $60K |
| Moderna, Inc. | $50K |
| Edwards Lifesciences LLC | $50K |
| Merck & Co. Inc. | $50K |
| Merck & Co. Inc. | $50K |
| Edwards Lifesciences LLC | $50K |
| Moderna, Inc. | $50K |
| Jazz Pharmaceuticals, Inc. | $50K |
| Jazz Pharmaceuticals, Inc. | $50K |
| Jpmorgan Chase Holdings LLC | $30K |
| Jpmorgan Chase Holdings LLC | $30K |
| Compass Pathways, Inc. | $30K |
| Takeda Pharmaceuticals America, Inc. | $20K |
| Takeda Pharmaceuticals America, Inc. | — |
| Compass Pathways, Inc. | — |
| Bristol-Myers Squibb Company | — |
| Medical Information Technology, Inc. | — |
Source: quarterly LD-2 disclosures filed under the Lobbying Disclosure Act. A fee covers everything the firm did for that client in the period, so it cannot be attributed to any one issue on the list. A filing that states no figure contributes nothing rather than a zero. Clients with no ticker are kept: a trade association or a foreign ministry is as much a part of what the firm does as a listed company.